Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
The Hospital of TangXian County, Hebei, 072350, China.
J Endocrinol Invest. 2019 May;42(5):591-598. doi: 10.1007/s40618-018-0959-0. Epub 2018 Oct 1.
Though type 2 diabetes mellitus (T2DM) is an important and independent risk factor for coronary artery disease (CAD) in the general population, the impact of T2DM on CAD in patients with familial hypercholesterolemia (FH) is less understood. Thus, the current study aimed to examine the features of FH patients with T2DM and explore the effects of T2DM on CAD in FH.
A total of 289 clinical heterozygous FH (HeFH) patients diagnosed with Dutch Lipid Clinic Criteria were consecutively recruited and divided into a T2DM group (n = 58) and non-T2DM group (n = 231). Clinical characteristics and laboratory findings were compared between the two groups. Target exome sequencing was used for gene mutation analysis.
HeFH patients with T2DM had significantly higher levels of triglycerides, body mass index and free fatty acids than did non-T2DM patients; moreover, patients with T2DM more frequently exhibited hypertension. However, the spectrum of FH-causing mutations was not significantly different (p = 0.061). Notably, patients with T2DM had higher prevalence of CAD (p = 0.012) and higher Gensini Score (p = 0.002). The regression analysis confirmed that HbA1c was an independent risk factor for both the presence and severity of CAD [OR 2.321 (1.098-4.904), p = 0.027; OR 1.349 (1.032-1.762), p = 0.028, respectively] in patients with HeFH.
Although there were not many differences in the clinical, lipid and genetic aspects of HeFH patients with and without T2DM, T2DM and HbA1c were associated with worse coronary lesions, suggesting that diabetes and the degree of blood glucose control are also important determinants of cardiovascular disease in these patients.
尽管 2 型糖尿病(T2DM)是普通人群中冠心病(CAD)的一个重要且独立的危险因素,但 T2DM 对家族性高胆固醇血症(FH)患者 CAD 的影响知之甚少。因此,本研究旨在研究 T2DM 合并 FH 患者的特点,并探讨 T2DM 对 FH 患者 CAD 的影响。
连续纳入 289 例符合荷兰血脂临床标准的杂合子 FH(HeFH)患者,分为 T2DM 组(n=58)和非 T2DM 组(n=231)。比较两组患者的临床特征和实验室检查结果。采用靶向外显子组测序进行基因突变分析。
与非 T2DM 患者相比,T2DM 合并 FH 患者的甘油三酯、体重指数和游离脂肪酸水平显著升高,且 T2DM 患者更常伴有高血压。然而,FH 致病突变谱无显著差异(p=0.061)。值得注意的是,T2DM 组患者 CAD 的患病率更高(p=0.012),Gensini 评分更高(p=0.002)。回归分析证实,HbA1c 是 HeFH 患者 CAD 存在和严重程度的独立危险因素[OR 2.321(1.098-4.904),p=0.027;OR 1.349(1.032-1.762),p=0.028]。
尽管 T2DM 合并和不合并 FH 的患者在临床、血脂和遗传方面差异不大,但 T2DM 和 HbA1c 与更严重的冠状动脉病变相关,提示糖尿病和血糖控制程度也是这些患者心血管疾病的重要决定因素。